Major or mild neurocognitive disorder due to Huntington's disease: Difference between revisions
Kiran Singh (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Huntington's disease}} | {{Huntington's disease}} | ||
{{CMG}}; {{AE}} {{KS}} | {{CMG}}; {{AE}} {{KS}} {{SAH}} | ||
==Overview== | ==Overview== |
Latest revision as of 15:02, 25 October 2018
Huntington's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Major or mild neurocognitive disorder due to Huntington's disease On the Web |
American Roentgen Ray Society Images of Major or mild neurocognitive disorder due to Huntington's disease |
FDA on Major or mild neurocognitive disorder due to Huntington's disease |
CDC on Major or mild neurocognitive disorder due to Huntington's disease |
Major or mild neurocognitive disorder due to Huntington's disease in the news |
Blogs on Major or mild neurocognitive disorder due to Huntington's disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2] Syed Ahsan Hussain, M.D.[3]
Overview
Major or Mild Neurocognitive Disorder Due to Huntington's Disease
DSM-V Diagnostic Criteria for Major or Mild Neurocognitive Disorder Due to Huntington's Disease[1]
“ |
AND
AND
AND
|
” |
Epidemiology and Demographics
Prevalence
The prevalence of Huntington's disease is 2,700 per 100,000 (2.7%) of the overall population.[1]
Risk Factors
- Genetic predisposition[1]
Differential Diagnosis
- Other mental disorders
- Other neurocognitive disorders
- Other movement disorders
- Drug-induced tardive dyskinesia
- Sydenham's chorea